CURE spoke with representatives of the National Pancreas Foundation on treatment options and outcomes for pancreatic cancer.
Avastin-Lonsurf Combo Improves Survival in Patients with Metastatic Colorectal Cancer Ineligible for Standard Chemo
Tecentriq-Avastin Combo Continues to Show Improved Survival Benefit in Patients with Advanced Liver Cancer
The Balancing Act of Being a Cancer Caregiver and Parent
Advanced-Stage Rare Type of Gastrointestinal Cancer More Common in Men, Associated with ‘Excellent’ 5-Year Survival Rates